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ABSTRACT: Protein engineering, chemical biology, and synthetic
biology would beneﬁt from toolkits of peptide and protein components
that could be exchanged reliably between systems while maintaining
their structural and functional integrity. Ideally, such components
should be highly deﬁned and predictable in all respects of sequence,
structure, stability, interactions, and function. To establish one such
toolkit, here we present a basis set of de novo designed α-helical coiled-
coil peptides that adopt deﬁned and well-characterized parallel dimeric,
trimeric, and tetrameric states. The designs are based on sequence-to-structure relationships both from the literature and analysis
of a database of known coiled-coil X-ray crystal structures. These give foreground sequences to specify the targeted oligomer state.
A key feature of the design process is that sequence positions outside of these sites are considered non-essential for structural
speciﬁcity; as such, they are referred to as the background, are kept non-descript, and are available for mutation as required later.
Synthetic peptides were characterized in solution by circular-dichroism spectroscopy and analytical ultracentrifugation, and their
structures were determined by X-ray crystallography. Intriguingly, a hitherto widely used empirical rule-of-thumb for coiled-coil
dimer speciﬁcation does not hold in the designed system. However, the desired oligomeric state is achieved by database-informed
redesign of that particular foreground and conﬁrmed experimentally. We envisage that the basis set will be of use in directing and
controlling protein assembly, with potential applications in chemical and synthetic biology. To help with such endeavors, we
introduce Pcomp, an on-line registry of peptide components for protein-design and synthetic-biology applications.
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One of the underlying tenets of the emerging ﬁeld ofsynthetic biology is to make the engineering of biological
systems easier and more reliable.1,2 This challenge can be
approached at a number of levels relating to engineering whole
genomes, clusters of genes and their products, and individual or
small collections of biomolecules.3,4 Whatever approach is
taken, a key theme is standardization and ultimately the design
and construction of standard parts or components that can be
used to perform similar tasks in diﬀerent contexts. At the
protein level, the synthetic-biology approach diﬀers from
traditional protein engineering, which has largely focused on
bespoke solutions to problems at hand and hence often
produces non-transferable outcomes. An alternative synthetic-
biology approach is to produce standard sets of polypeptide
components, i.e., toolkits, that are designed and fully
characterized once, but which can be used in a “plug-and-
play” manner to solve problems across many diﬀerent
systems.5,6 To succeed, the components of such toolkits should
be fully characterized in all respects from sequence through to
structure, function, and interactions. For this reason, de novo
designed components of reduced complexity where the role of
every residue is understood may oﬀer certain advantages over
more-complex sequences appropriated from nature.
Among the desired components are tunable protein−protein
interaction motifs, which might be used as hubs, scaﬀolds, and
nucleators for other biomolecular assemblies and functions
both in vitro and in vivo. There are many natural protein
domains that could be used as starting points for the
construction of protein−protein interaction components.7,8
However, another consideration is that components should be
designable or at least engineerable, and this requires a good
understanding of sequence-to-structure relationships for the
targets. This requirement points to using rational de novo
designed peptides. Sequence-to-structure relationships in
proteins are immensely complex and are not fully understood.
The ability to design folded proteins reliably and using a small
number of rules-of-thumb is limited to a small number of
speciﬁc examples, for instance, zinc ﬁngers and collagens,3,9−12
though other structures, including truly de novo structures,
protein−protein interactions, and enzyme-like function have
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been accessed using computational approaches.13−15 α-Helical
coiled-coil proteins, however, have considerable advantages in
terms of designability.16
Coiled coils exhibit possibly the greatest geometric diversity
of protein−protein interactions in terms of number, orienta-
tion, and constitution of interacting elements.17,18 In addition,
due to their abundance in nature, the large number of available
X-ray crystal structures, and a plethora of experimental and
theoretical studies over the past two decades, there are
established rules-of-thumb that relate protein sequence and
structure in coiled-coil domains.16 These features make coiled
coils attractive and tractable targets for rational protein design
and in contributing to the construction of toolkits of peptide
and protein components for synthetic biology.
In terms of sequence, coiled-coil domains are found on
average in ∼3% of protein-encoding regions across all
genomes.19 They often exhibit a heptad repeat of hydrophobic
(H) and polar (P) residues, HPPHPPP, usually denoted
abcdefg, and most coiled coils have 4 or more contiguous
heptad repeats. In structural terms (Figure 1), these patterns
encode amphipathic α-helices, which assemble to bury the
hydrophobic surface formed by the a and d residues. The slight
mismatch between the periodicity of these hydrophobic
residues and the α-helix3.5 residues versus 3.6 residues/
turn, respectivelyleads to a left-handed supercoiling of the
helices around each other and to characteristic and intimate
knobs-into-holes side-chain packing between these helices.20,21
Although this binding is primarily hydrophobic, the e and g
positions ﬂank the hydrophobic core and present possibilities
for interhelix salt-bridging interactions. These apparently
straightforward sequence-to-structure relationships mask con-
siderable structural variety: classical coiled coils can have
between 2 and 6 helices,22 and more complex assemblies are
possible.18,23 The helices can be arranged in parallel,
antiparallel, or mixed topologies in both homo- and heterotypic
assemblies.17,18,23 However, the precise energetic factors that
discriminate between these various arrangements remain
incompletely understood.
Though other states have been targeted successfully on an
individual or bespoke basis, much of the work in coiled-coil de
novo design has focused on dimers.16,26 This work has
culminated in the generation of partner-selective sets of
orthogonal, that is, independently folding, heterodimeric coiled
coils.27−29 Undoubtedly, these will be of use in directing and
cementing pairwise protein−protein interactions both in vitro
and in vivo and in synthetic biology applications.5,6 Here we
focus on generating a set of parallel dimeric, trimeric, and
tetrameric coiled-coil peptides, which constitute the major
structural classes observed in known coiled-coil structures.18
We regard these structures as the starting point for a toolkit of
coiled coils, or a coiled-coil basis set. Our aims in this study
were (1) to design these peptides de novo to facilitate
understanding of sequence-to-structure relationships within
the set; (2) to characterize the peptides as fully as possible both
in solution and through X-ray crystallography; and (3) to
deliver a robust set of peptides that can be manipulated
precisely and predictably in future protein engineering and
synthetic biology applications.5,22,30
■ RESULTS AND DISCUSSION
Rational Peptide Design. Residues at the g, a, d, and e
sites of the heptad repeat predominantly deﬁne the helix−helix
interfaces in the vast majority of coiled-coil assemblies.17,21,23
Therefore, we aimed initially to establish combinations of
residues at these foreground sites to direct de novo peptide
sequences into the diﬀerent target oligomer states, namely,
parallel dimer, trimer, and tetramer.
The seminal work of Harbury et al. on the leucine-zipper
peptide (GNC4-p1) from the yeast transcriptional activator
GCN4 provided the starting point for our designs.31,32 In this
study, combinations of isoleucine (Ile, I) and leucine (Leu, L)
at the a and d positions of GCN4-p1 yield three diﬀerent
oligomer states: Ile at a plus Leu at d gives a dimer, Ile at both
positions results in a trimer, and Leu at a plus Ile at d leads to a
tetramer. Thus, for our starting set of sequences, we used these
combinations at a and d in the peptides CC-pIL, CC-pII and
CC-pLI, respectively (Table 1).
Next, we selected the amino acids at the core-ﬂanking g and e
sites. In natural coiled-coil sequences these are predominantly
occupied by polar residues. More speciﬁcally, we found in
parallel, homo-oligomers from the CC+ database25 that
glutamic acid (Glu, E), glutamine (Gln, Q), lysine (Lys, K),
and less frequently arginine (Arg, R) dominate these positions
(Supplementary Table S1). In addition, in these structures,
there is the potential for gh:e′h+1 salt-bridging interactions,
where subscripts h and h+1 signify consecutive heptads and the
prime signiﬁes a diﬀerent peptide chain. On this basis, we chose
Glu at g and Lys at e for all three starting sequences.
With the initial foreground g, a, d, and e positions of the
starting sequences set, the remaining background positions (b, c,
Figure 1. Coiled-coil assemblies. (A) Helical-wheel diagram showing
the heptad repeat conﬁgured as a helix with 3.5 residues per turn, i.e.,
eﬀectively incorporating the supercoil. Leaf shapes indicate the
direction of the Cα−Cβ vectors. Hydrophobic residues at the a and
d positions provide most of the binding enthalpy, augmented by ion-
pairing or hydrogen-bonding interactions between polar residues at
opposing e and g positions. The b, c, and f positions are distant from
the interface. (B) View down the long axis of a typical parallel, dimeric
coiled coil (PDB ID 2ZTA24). Coloring of the heptad positions,
abcdefg, follows the CC+ standard for heptad positions (a = red; b =
orange; c = yellow; d = green; e = cyan; f = blue; g = magenta).25
Structural images created using PyMol (http://www.pymol.org).
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and f) were kept the same in each peptide. These were
designed to contribute to the overall stability of the assembly
without favoring any particular oligomer state, i.e., to promote
helicity only, and also to be exchangeable for other side chains
in the future, as follows: for the designs presented here, b and c
positions were made alanine as this is a small, helix-favoring and
otherwise largely non-discriminating amino acid. The f
positions were populated with combinations of Gln, Lys and
tryptophan (Trp, W), to favor helicity and to improve solubility
(Gln and Lys) and to provide a UV chromophore (Trp),
respectively. Our analysis of CC+ also revealed that Ala, Gln,
and Lys were among the most frequently observed amino acids
at b, c, and f (Supplementary Tables S1 and S2). For some of
our designed peptides, additional variants were made in which
the Trp residues were replaced by 4-iodo-L-phenylalanine
(iodo-Phe, Φ) to aid structure determination by X-ray
crystallography.33
To provide suﬃcient stability, the sequences were made 4
heptads, i.e., 28 residues, long and were additionally capped
with a Gly residue at each end. Finally, each sequence was
distinguished by appending a two-residue sequence outside the
helical region to give it a unique mass. The resulting sequences,
which were named CC-pIL, CC-pII, and CC-pLI, respectively,
are shown in Table 1, and a full set of sequences (including the
iodo-Phe variants) are in Supplementary Table S3.
Solution-Phase Biophysical Characterization. The
three sequences CC-pIL, CC-pII, and CC-pLI were synthesized
by standard Fmoc solid-phase peptide synthesis, puriﬁed by
reversed-phase HPLC, and conﬁrmed by MALDI-TOF mass
spectrometry (Supplementary Figure S1). We used circular
dichroism (CD) spectroscopy to probe the nature and stability
of secondary structure in the peptides. At 20 °C all three gave
CD spectra consistent with near-complete α-helix formation
(Figure 2A and Supplementary Figure S2), that is, with mean
residue ellipticities at 222 nm (MRE222) of ca. −34,000 to
−40,000 deg cm2 dmol−1 res−1, Table 2. Moreover, in each case
the structures showed high thermal stability, with minimal
denaturation, and no cooperative melting transition at temper-
atures up to 90 °C at 50 μM peptide concentrations, Figure 2B.
N.B.: we interpret the slight, linear loss of MRE222 with
increasing temperature as fraying of the termini of the helices.34
Consistent with this, in the X-ray crystal structures reported
below, we found increased B-factors for both the N- and C-
terminal residues for all of our designed peptides (Supple-
mentary Figure S3). In solution, reducing the peptide
concentrations to 10 μM only revealed the beginnings of
thermal unfolding curves above ∼70 °C (Supplementary Figure
S4). Therefore, to access the full unfolding behavior of the
peptides, we performed the thermal denaturation experiments
in the presence of 3 M guanidinium chloride. These showed
reversible, sigmoidal unfolding curves (Figure 2C, Supplemen-
tary Figure S4, and Table 2). Together, these CD data are
consistent with CC-pIL, CC-pII, and CC-pLI folding to form
thermally stable, cooperatively folded, and discrete helical
bundles as designed.
To assess the size of the bundles formed, we turned to
analytical ultracentrifugation (AUC). Sedimentation-equili-
brium experiments for each peptide gave data that were readily
interpreted by ﬁts assuming single-ideal species, and more
complex ﬁtting to monomer−oligomer models was not
necessary; in each case, the former returned oligomers with
integer numbers of monomers. CC-pII and CC-pLI were
trimeric and tetrameric, respectively, consistent with our design
strategy and Harbury’s experiments on GCN4-p1.31,32 How-
ever, and to our surprise, CC-pIL was trimeric in solution.
Consistent with these data, dynamic light scattering (DLS)
measurements gave hydrodynamic diameters in the order CC-
pLI > CC-pII ≈ CC-pIL (Supplementary Figure S6). These
results challenge many ﬁrst-order assumptions in the literature,
including our own, that peptides with a = Ile and d = Leu
should be dimeric.3,16 This inspired further investigation.
X-ray Crystal Structures. To gain further structural insight
into the assemblies of CC-pIL, CC-pII, and CC-pLI, X-ray
crystal structures were determined using a combination of
molecular replacement and single wavelength anomalous
diﬀraction methods. The latter used experimental phases
from iodine atoms incorporated via iodo-Phe in place of Trp
(Supplementary Table S3). Full details of crystallization,
structure determination, and reﬁnement are given in Supple-
mentary Tables S4 and S5.
The X-ray crystal structures revealed that each peptide
formed parallel, blunt-ended assemblies, as per the design
strategy, with oligomer states matching those observed in
solution, i.e., CC-pIL and CC-pII were trimers, and CC-pLI
was tetrameric. As judged by the program SOCKET,21 all three
assemblies had “knobs-into-holes” side-chain packing centered
on a single hydrophobic seam of a and d residues (Figure 3,
Supplementary Table S6) and, as determined by TWISTER,35
Table 1. Sequences and Heptad Register for the Designed Coiled-Coil Peptidesa
aThese were given unique mass and chromophoric signatures.
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had helical and superhelical parameters characteristic of classical
coiled-coil assemblies (Supplementary Table S7).
In more detail, the core-packing angles made by the a and d
“knob” residues into their respective “holes” for all three
Figure 2. Solution-phase characterization of the designed coiled-coil peptides. (A) CD spectra recorded at 20 °C. (B) Thermal unfolding curves
followed by CD spectroscopy. (C) Thermal denaturation curves in the presence of 3 M guanidine hydrochloride. (D) Representative AUC
sedimentation equilibrium data (crosses) recorded at 20 °C and 46,000 rpm rotor speed in a Beckman AN60 Ti rotor and ﬁts (lines). Key: CC-pIL,
solid black lines; CC-pII, solid red lines; CC-pLI, solid blue lines; CC-pIL-I17N, broken black lines; and CC-pII-I13N, broken red lines. All samples
were in phosphate-buﬀered saline (PBS) at pH 7.4. For panels A, B, and C, 50 μM peptide concentrations were used. For panel D concentrations
were between 75 and 400 μM, giving an initial A280 of 0.4 AU. AUC data for CC-pII-I13N are given in Supplementary Figure S5.
Table 2. Biophysical Parameters for the Designed Coiled-Coil Peptidesa
systematic
name
basis-set
name
MRE222 (deg cm
2
dmol−1·res−1) TM (°C)
KT,1/2 (M) (T = 20 °C);
(T = 37 °C)
n
solution
n X-ray crystallography (PDB
ID)
CC-pIL −38179 >90 (77.44) n/d 3 3 (4DZN*)
CC-pIL-I17N CC-Di −37844 78.15 6.67 × 10−11; 5.54 × 10−9 2 2 (4DZM*)
CC-pII CC-Tri −39293 >90 (60.09) n/d 3 3 (4DZL*)
CC-pII-I13N CC-Tri-N13 −32232 56.47 1.74 × 10−8; 9.42 × 10−7 3 3 (4DZK)
CC-pLI CC-Tet −32808 >90 (63.18) n/d 4 4 (3R4A)
aMRE values are for peptide at 50 μM peptide concentration in PBS at 20 °C. TM values are for the mid-point of thermal denaturation at 50 μM
peptide concentration in PBS, and values in parentheses indicate TM in the presence of 3 M guanidine hydrochloride. K1/2,T is the concentration at
which the complex is half folded, as judged by MRE222, for the given temperature. n Refers to the number of helices in the assemblies. PDB Codes
marked with an asterisk are for the 4-iodophenylalanine derivative.
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structures ﬁtted with the distributions measured for other
classical coiled coils of known structure (Supplementary Figure
S7). Speciﬁcally, the core residues in CC-pIL and CC-pII had
“acute” packing arrangements typical of parallel trimers, and
although the structure is less symmetrical, those in CC-pLI had
alternating “perpendicular” and “parallel” packing at a and d,
respectively.
As CC-pII and CC-pLI conformed to our design expect-
ations, we renamed these CC-Tri and CC-Tet, respectively, to
signify that they form part of our designed coiled-coil basis set,
Table 1. As stated above, CC-pIL unexpectedly formed a
classical coiled-coil trimer with canonical knobs-into-holes
interactions. This contrasts with the same a = Ile d = Leu
sequence in the GCN4-p1 background, which forms a parallel
dimer in solution.31 N.B.: A crystal structure for this variant has
not been reported. Therefore, we turned to the task of
engineering dimer speciﬁcity into the CC-pIL foreground and
to our initial goal of making a true Basis-set dimer, CC-Di.
Negative Design: Specifying Dimer in CC-pIL. The
problem of specifying a particular oligomer state can be
addressed by negative design, which entails energetically
destabilizing any unwanted states relative to the target state,
which may itself be destabilized to some extent by the change.
Ideally, we wanted a single point mutation, or at least a small
number of such mutations, to eﬀect the switch from trimer to
dimer in CC-pIL. In other words, we required an amino acid
with a large oligomer-state discrimination factor (ODF)
between parallel dimer and trimer when placed at a speciﬁc
site in the sequence.
To inform our choice, we turned to the CC+ database of
structurally veriﬁed coiled coils.25 We collated all examples of
canonical (i.e., heptad-based), parallel, homodimers and
-trimers that were >21 residues long and had <50% sequence
identity. This gave sets of 90 dimers and 43 trimers, with ∼500
and ∼220 heptad repeats in total, respectively (Supplementary
Table S2). We focused on residues at the a and d sites, as
mutations here were anticipated to have the largest eﬀects on
oligomer state, and selected only those that occurred at >5% in
either of the a or d sites in the dimer or trimer sets; this was an
arbitrarily chosen cutoﬀ, which nonetheless covered 80% and
88% of the counts at the a and d sites in the dimer and trimer
sets, respectively. This gave the following reduced set of
preferred side chains at one or both of the sites in coiled-coil
dimers and trimers: Ala, Ile, Lys, Leu, Asn (asparagine, N), Gln,
and Val (valine, V). Next, we calculated the ODFs for these
residues at both positions, Figure 4. We deﬁne ODF as the
log10 of the ratio of the normalized percentages of the amino
acid at the particular site in the dimer and the trimer
(Supplementary Table S2). We ﬁnd this so-called log-odds
scoring useful as positive ODF values reveal preferences for
dimer, and negative values are indicative of trimer.36 It is
important to stress, however, that this analysis assesses the
impact of individual residues on oligomer state, and ignores any
pairwise or higher-order side-chain interactions.37 Despite this
limitation, this method highlights ﬁrst-order eﬀects and directs
straightforward experiments.
The ODF values are intriguing in themselves for a number of
reasons. First, Leu, which is the most frequently found residue
Figure 3. Structures formed by the designed coiled-coil peptides CC-pIL, CC-pII and CC-pLI. (A−C) Helical-wheel diagrams for trimeric and
tetrameric coiled coils, showing sequences and heptad assignments. One-heptad slices through the X-ray crystal structures of CC-pIL (D, gray
ribbon, PDB ID 4DZN), CC-pII (E, red, PDB ID 4DZL), and CC-pLI (F, blue, PDB ID 3R4A). Key features include the knobs-into-holes
interactions formed by the isoleucine (cyan) and leucine residues (magenta) at the a/d positions and sub-4 Å salt-bridge interactions between Glu at
g and Lys at the following e positions (shown as broken black lines). All images were created in PyMol (http://www.pymol.org), are viewed along
the axis of the bottom-left helix from the N- to C-terminus, and cover one complete heptad register, gabcdef.
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in both coiled-coil data sets, appears to be oligomer-state
agnostic at both a and d. The β-branched amino acids, Ile and
Val, are non-discriminating at a but favor the trimer when
placed at d. This immediately explains why the a = Ile, d = Leu
foreground of CC-pIL does not necessarily favor dimers, and
considering the earlier studies on GCN4-p1,31 it indicates that
other factors within that background render GCN4-pIL a
dimer. Nevertheless, of those selected for this study and
Harbury’s work on GCN4, this foreground appears to be one of
the best starting points for making a dimer, because anything
with Ile (or Val) at d strongly favors a trimer. Alternative
foregrounds are a = Leu, d = Leu or a = Val, d = Leu, but
considering the low overall speciﬁcity conferred by all of these a
and d combinations the a = Ile, d = Leu foreground was
retained, and dimer speciﬁcity was sought through point
mutation of the CC-pIL peptide.
Returning to the question of what point mutation to make to
switch CC-pIL from trimer to dimer, the choice was either to
incorporate Asn at a or Lys at a or d, as only these residue
placements had ODF ≫ 0.3, i.e., strongly favoring dimers,
Figure 4. We chose the former for several reasons. First, Asn
occurs more frequently than Lys at the a and d sites of coiled
coils overall; second, it has a higher coiled-coil propensity
overall compared with Lys (Supplementary Figure S9); third,
and interestingly, the other placement, Asn at d, favors the
trimer, which we return to below; and ﬁnally, it is known
empirically that Asn at a is strongly associated with dimeric
states.38−40 To have the maximum impact on the structure and
consistent with the conserved positioning of Asn at the a site of
the third heptad repeat of leucine-zipper peptides including
GCN4, we made the Ile-to-Asn mutation in the middle of the
sequence at the a site of the third heptad repeat of CC-pIL to
give CC-pIL-I17N, Table 1. N.B.: we have also found
substitution at this position to be optimal for the CC-pIL
system, as we will describe elsewhere (Fletcher et al.,
unpublished data).
At low temperatures, the CC-pIL-I17N peptide was as helical
as its parent, Figures 2A and B. However, the mutant was less
stable to heat, showing a classical sigmoidal and reversible
thermal unfolding transition with a midpoint of 78 °C at 50 μM
peptide concentration, Figure 2B. This is consistent with the
anticipated destabilizing eﬀect of including a polar side chain
within the otherwise hydrophobic core of the peptide assembly.
Moreover, AUC analysis revealed that CC-pIL-I17N was
dimeric in solution, Figure 2D, and the X-ray crystal structure
conﬁrmed the desired parallel dimer, Figure 5. Thus, we
achieved CC-Di with two design iterations.
The X-ray crystal structure of CC-Di is noteworthy because
the asparagine side chains are not involved in any hydrogen
bonding contacts with each other, Figure 5A and B. Related to
this, we have found that about two-thirds of the similarly buried
Asn side chains in parallel coiled-coil dimers make interhelical
hydrogen bonds (Supplementary Figure S10). This suggests
that their inﬂuence in specifying oligomer state is more
complicated than has often been argued16,38−40 and that this is
not necessarily mediated by well-deﬁned interhelical inter-
actions. Put another way, in the absence of any hydrogen-
bonded interactions, burying the amide components of Asn
side chains destabilizes all homo-oligomeric coiled coils, but the
penalty is expected to be less severe for dimers, which partly
bury only two such side chains, compared with higher-oligomer
states that bury more. These arguments carry the caveat that
there may be discrepancies between the fundamental dynamic
nature of protein structures and the snap shots of these
aﬀorded through X-ray crystallography.
Second, and returning to the discussion of the gh:e′h+1
Glu:Lys salt-bridge interactions, in the parent, CC-pIL trimer,
all possible 12 interactions are made, Figure 3D. However, in
CC-Di, only 2 of the possible 8 interactions are made, and this
is only in one of the two dimers observed in X-ray crystal
structure (Figure 5A and B and Supplementarya Table S8); all
of the other Cδ to Nζ distances are ≥4.5 Å. Thus, in CC-pIL,
which from the ODFs of Figure 4 have an oligomer-state-
agnostic core, the balance may be tipped toward the trimer
state because this allows closer contact of the gh and e′h+1
residues and salt-bridge formation.
Revisiting GCN4-pIL. As mentioned above, an X-ray
structure for GCN4-pIL has not been reported. However,
solution-phase data indicate that the peptide is dimeric.31 This
Figure 4. Oligomer-state discrimination factors (ODFs) for individual
amino acids in parallel, homomeric coiled-coil dimers and trimers.
ODFs were calculated as the log10 of the ratio of the normalized
percentages of each amino acid at the speciﬁed positions: a (black
bars) and d (gray bars), in the dimer and trimer data sets. The shaded
region highlights ODFs in the range +0.3 and −0.3, i.e., preferences for
dimer and trimer, respectively, of no more than twice the alternative
oligomer state. Propensity is deﬁned as the ratio of observed residue
counts at a deﬁned register position, divided by the expected count for
the same residue at the same position, where the latter is calculated by
a standard contingency table analysis, Supplementary Table S2. In this
way, biases due to the diﬀerent sizes and compositions of the data sets
are accounted for, although we found the ﬁnal relative values largely
insensitive to the normalization procedure. N.B.: There were no
examples of Lys at a or d in trimers; however, given the high
occurrence of Lys at a in dimers (6%), we felt it important to assess
the ODFs for this residue. Thus, to avoid inﬁnite (or zero) ODFs, a
dummy count of 1 was added to the raw count for every residue.
Therefore, the absolute magnitude of the ODFs for Lys is dictated by
this dummy count, and these values should only be qualitatively
compared to other ODFs. Errors on the count data for the dimers and
trimers were estimated using the normal distribution and propagated
through the ODF calculation, with the error bars shown indicating 1
standard deviation. Starred data shown without error bars failed to
meet the criteria for the normal approximation to the binomial
distribution, as a result of one or more of the contributing count data
elements being less than 5. The method was also extended to the e and
g positions, for which the ODF values were smaller, reﬂecting the
lower steric contribution of these residues to the binding surface,
Supplementary Figure S8. Furthermore, as an aid to design, the ODF
values for each position can be correlated to the coiled-coil propensity
of a given residue (Supplementary Figure S9). Finally, there were
insuﬃcient data for natural parallel coiled-coil tetramers to extend the
analysis to this state.
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contrasts with our ﬁndings for a = Ile, d = Leu, albeit in a
diﬀerent background, and interestingly with those on another
related design sequence, essentially (IAALEQK)4, which also
forms a parallel trimer in solution.41 Given the importance of
the GCN4 system in the development of the coiled-coil and
protein-folding ﬁelds, its applications in protein engineering
and design, and the necessity for robust design principles, we
felt it important to try to reconcile these diﬀerences. Therefore,
we synthesized GCN4-pIL (Supplementary Table S3) and
characterized it in solution (Supplementary Figures S2 and S5).
As expected the peptide was fully helical and stable in solution.
However, we found that it sedimented with a molecular weight
somewhere between that of dimer and trimer, depending on
concentration. This ambiguity was also consistent with our
inability to solve the crystal structure of this peptide: the space
group of the crystal, and the asymmetric unit content were
equally consistent with dimers or trimers in the crystal lattice.
Together these observations suggest that the oligomerization
state adopted by GCN4-pIL may be more condition-dependent
than originally thought and that the energetic diﬀerence
between dimeric and trimeric states for this particular sequence
is small.
Negative Design: Modulating the Stabilities of CC-Tri
and CC-Di. Interestingly, aside from Ile or Val at d, the single-
residue placement that most favors trimers is Asn at d, Figure 4.
Again, this has recently been corroborated experimentally.42
Therefore, we explored the inclusion of a single Asn at a d
position in CC-Tri: in this case, Ile-13 in the second heptad was
mutated to give CC-Tri-N13, Table 1. As with CC-Di, this
peptide was less stable than its parent, showing co-operative
thermal denaturation with a TM of 56.5 °C at 50 μM
concentration. In this case, however, a change in oligomer
state was not expected and, indeed, was not observed: the
peptide was trimeric in solution by AUC, Table 2, and the X-
ray crystal structure conﬁrmed a parallel trimer, Figure 5D. The
Asn side chains are accommodated without signiﬁcant steric
penalty but bind a chloride ion. Similar constellations have been
observed in both natural and engineered coiled coils42 and
presumably help oﬀset some but not all of the energetic penalty
of including asparagine in the hydrophobic core. In summary,
combined these studies lend weight to the idea that this residue
placement helps further to specify oligomer state, ameliorates
the stability of an all-hydrophobic core, and may possibly help
in partner selection. All in all, and like speciﬁc positioning of
Asn at a in dimers, it provides a further rule-of-thumb for
tuning trimeric coiled-coil interactions.
Developing this last point, an important requirement for
using the coiled-coil basis set in protein engineering and
synthetic biology will be the ability to adjust complex stabilities
to suit diﬀerent applications. The high stabilities of CC-pIL,
CC-Tri, and CC-Tet mitigate this; essentially, these peptides
are oligomeric under all practically accessible concentrations.
The inclusion of Asn at a and d of CC-Di and CC-Tri-N13,
respectively, ameliorates their stabilities. Conventionally, the
stabilities of biomolecular complexes are described in terms of a
dissociation constant, KD, i.e., the concentration at which the
molecules are half associated and half dissociated. However, for
states above dimer, this term is not simply that concentration
but the concentration raised to the power n − 1, where n is the
oligomeric state. Therefore to quantify oligomer-state stability
more practically, we measured the midpoint of thermal
unfolding (TM) for CC-Di and CC-Tri-N13 over a range of
concentrations (Supplementary Figure S11 and Table S9).
From these data, the concentration at which the complex is half
formed for any given temperature, K1/2,T,
43 could be
determined. For example, for CC-Di and CC-Tri-N13 at 37
°C, the values were in the nanomolar and micromolar regimes,
respectively, Table 2. We argue that this parameter will be more
useful to practicing protein engineers or synthetic biologists.
Conclusions, Implications, and Applications. The
studies described herein provide the foundations for a toolkit
or a basis set of de novo designed coiled-coil peptides of
speciﬁed oligomer state, namely, parallel dimer (CC-Di), trimer
(CC-Tri), and tetramer (CC-Tet). The designs incorporate
previously known rules for oligomer-state selection that center
on the hydrophobic core residues a and d placed within a
designed and presumed oligomer-state-agnostic background.
These studies conﬁrm that a = d = Ile and a = Leu and d = Ile
are good rules for specifying parallel trimeric and tetrameric
coiled coils, respectively, as reported previously.31,32 Moreover,
our work demonstrates that these rules are robust in that they
can be transferred from natural to fully designed backgrounds.
However, and surprisingly, our initial design iteration for the
targeted dimer, CC-pIL, reveals that a foregoing rule-of-thumb,
Figure 5. X-ray crystal structures of the basis-set dimer and trimer peptides. (A, B) CC-Di. (C) CC-Tri. (D) CC-Tri-N13. The two nonidentical
dimer assemblies from the CC-pIL-I17N unit cell (PDB ID 4DZM) are shown in panels A and B for completeness. Putative hydrogen bonds, taking
into account side-chain ﬂexibility, are indicated with a dashed line, with distances ranging from 2.4 to 3.5 Å. For the polar side chains CPK coloring is
used, while Leu and Ile side chains are colored magenta and cyan, respectively. Structural images were created using PyMol (http://www.pymol.org).
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a = Ile and d = Leu, is not suﬃcient in itself to specify dimer;
the peptide is trimeric both in solution and the crystal state. To
solve this problem, based on the literature and analysis of a
database of known coiled-coil structures, we made a single Ile-
to-Asn substitution at a central a position, and the resulting
peptide, CC-Di, is a parallel dimer.
The ﬁnding that the oligomeric state of a ∼30-residue
peptide can be switched by a single-residue change indicates
that the energetic diﬀerence between some coiled-coil states is
small. This implies that the free-energy landscape of coiled-coil
assemblies is complex and is unlikely to be typiﬁed by only few
distinct minima. In other words, some eﬀort has to be made to
locate stable minima for desired states. Deﬁning this energy
landscape better will be non-trivial. We envisage that the coiled-
coil basis set and variants within it will contribute to mapping
this energy landscape.
These studies aﬃrm that the set of CC-Di, CC-Tri, and CC-
Tet provides a robust set of stand-alone peptides that are
characterized to a very high level in terms of sequence, solution-
phase behavior and 3D structure, thus meeting many of our
initial requirements for a toolkit of peptide components for
protein engineering and synthetic biology. Moreover, the basis
set has the potential to be used to provide oligomerization
domains for a variety of the chemical and synthetic biology
studies. Indeed, we have already shown that CC-Tri acts as a
hub to nucleate the folding and assembly of bacterial collagen
sequences;30 that CC-Tet presents a scaﬀold to explore larger
oligomeric states;22 and that CC-Di and CC-Tri can be used to
study fundamental sequence-to-structure relationships in coiled
coils (Fletcher et al., unpublished).
Toward a Registry of Peptide Components (Pcomp)
for Synthetic Biology. Finally, and as an aid to protein
engineers and synthetic biologists, we have constructed a
database, Pcomp (http://coiledcoils.chm.bris.ac.uk/pcomp/).
This is a repository for structural and functional information
for peptide components, with the coiled-coil basis set as its ﬁrst
occupants. The database is searchable by component structural
type and houses data relating to component synthesis and
biochemical, structural, and functional characterizations. In
addition, Pcomp provides downloadable datasheets summariz-
ing the full characterization of the components (Supplementary
Figure S12). The overall aim of Pcomp is to provide all of the
information necessary on robust synthetic components that
might be used in a “plug-and-play” fashion to construct more
complex systems, i.e., to perform a similar role to that of the
Registry of Standard Biological Parts oﬀered by the BioBricks
foundation.44 The database is freely accessible, and we welcome
input and contributions from others.
■ METHODS
General. All Fmoc-amino acid derivatives, coupling agents,
and peptide grade DMF were purchased from AGTC
Bioproducts (Hessle, U.K.), with the exception of Fmoc-L-4-
iodophenylalanine, which was purchased from GL Biochem
(Shanghai, PRC). Triﬂuoroacetic acid and piperidine were
purchased from Fisher Scientiﬁc (Loughborough, U.K.). Mass
spectrometry was carried out on an Applied Biosystems 4700
Proteomics Analyzer MALDI instrument. All experiments were
carried out in phosphate-buﬀered saline (PBS) (137 mM NaCl,
2.7 mM KCl, and 10 mM phosphate buﬀer at pH 7.4), unless
otherwise stated. Crystallographic screens were purchased from
Molecular Dimensions Ltd. (Suﬀolk, U.K.). X-ray diﬀraction
data were collected at Diamond Light Source Ltd., Harwell
Campus, Didcot, Oxfordshire, U.K.
Peptide Synthesis. All peptides were synthesized on a 0.1
mmol scale on Rink amide chemmatrix resin. Synthesis was
conducted via standard Fmoc protocols on a CEM microwave-
assisted peptide synthesizer, making use of HBTU activation.
Prior to cleavage from the solid support the peptide was N-
terminally acetylated using acetic anhydride/pyridine in DMF.
Cleavage from the resin was eﬀected with a 95:5:5 mix (10 mL)
of triﬂuoroacetic acid, triisopropylsilane, and water. The resin
was washed with additional triﬂuoroacetic acid (5 mL), and the
combined acid extracts were concentrated to approximately 5
mL under a ﬂow of nitrogen. The crude peptide was then
precipitated by addition of cold diethyl ether (40 mL) to give
an oﬀ-white precipitate that was isolated by centrifugation. The
precipitate was redissolved in ca. 10 mL of a 1:1 mix of
acetonitrile and water prior to freeze-drying to yield a ﬁne white
solid. Peptides were puriﬁed by reverse-phase HPLC using a
Kromatek C18HQsil column (150 by 10 mm) running a linear
gradient of acetonitrile and water, each containing 0.1% TFA. A
typical gradient ran from 20% to 80% acetonitrile over 30 min.
Circular Dichroism Spectroscopy. CD spectra were
obtained using a JASCO J-810 spectropolarimeter ﬁtted with
a Peltier temperature controller. Peptide concentrations were
determined by UV absorption (ε280(Trp) = 5690 mol
−1 cm−1;
ε280(Tyr) = 1280 mol
−1 cm−1). Peptide solutions were prepared
in PBS and examined in 1 mm (50−100 μM samples), 5 mm
(5−10 μM), and 10 mm (50−100 nM) quartz cuvettes.
Thermal denaturation experiments were performed by ramping
temperature from 5 to 90 °C at a rate of 10 °C h−1. Full spectra
were recorded at 5 °C intervals, and the CD at 222 nm was
recorded at 1 °C intervals (1 nm interval, 1 nm bandwidth, 16 s
response time). The midpoint of thermal denaturation (TM)
values were determined from the second derivative of the
variable temperature slope.
Analytical Ultracentrifugation. Sedimentation equili-
brium experiments were conducted at 20 °C in a Beckman-
Optima XL-I analytical ultracentrifuge using an An-60 Ti rotor.
Solutions were prepared in PBS with peptide concentrations in
the range 75−400 μM and spun at speeds in the range 20,000−
50,000 rpm. Data sets were initially ﬁtted to a single, ideal
species model using Ultrascan (http://www.ultrascan.uthscsa.
edu/). The partial speciﬁc volume for each of the various
peptides and the solvent density was calculated using Sednterp
(http://www.jphilo.mailway.com/download.htm).
Dynamic Light Scattering. Measurements were made
using a Malvern Zetasizer Nanoseries instrument. Samples were
prepared at 100 μM peptide concentration in PBS. Samples
were centrifuged prior to analysis to remove any large
particulate material. Measurements were made at 20 °C using
automated settings. The data were analyzed using the
associated DTS Nano particle sizing software.
X-ray Crystallography: Crystallization. All peptides were
crystallized using the sitting drop vapor diﬀusion method at 18
°C. For crystallization peptide solutions were prepared
unbuﬀered in ultrapure water at the following concentrations:
CC-pIL-I17N 8 mg mL−1, CC-pIL 8 mg mL−1, CC-pII-I13N
20 mg mL−1, CC-pII 15 mg mL−1, CC-pLI 10 mg mL−1. For
preparation of halide-derivative crystals iodo-phenylalanine
containing peptides were used. Initial screens were generally
carried out using a sparse matrix approach with a total number
of 480 conditions of commercially available screens. Screens
were prepared in 96-well MRC plates using the robotic Phoenix
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Liquid Handling System (Art Robbins, Sunnyvale, CA, USA)
with reservoir volumes of 50 μL and peptide drop volumes of
200 nL mixed with 200 nL of reservoir solution. Diﬀraction
quality crystals were usually obtained within 1−4 weeks with
optimization of initial crystal hits carried out as necessary. Final
crystallization conditions for all peptides can be found in
Supplementary Table S4.
X-ray Crystallography: Data Collection and Process-
ing. Complete sets of diﬀraction data for all peptides were
collected from loop mounted single crystals under cryo
conditions at 100 K using a ADSC Q315 CCD detector at
synchrotron beamlines IO2 or IO4 of Diamond Light Source
Ltd., Harwell Campus, Didcot, Oxfordshire, U.K. Prior to loop
mounting crystals were soaked in appropriate cryoprotectant
solutions (usually 20−30% PEG400 or glycerol) where
necessary. Data collection was carried out either at a
wavelength of 0.98 Å for native data sets or at 1.7 Å for
collection of anomalous data from iodide-derivatized crystals
(Supplementary Table S5). Data indexing, integration and
scaling were carried out for CC-pII-I13N and CC-pIL with
MOSFLM45 and SCALA,46 for CC-pII with HKL-200047 or for
CC-pIL-I17N with XDS.48 Data collection statistics can be
found in Supplementary Table S5.
X-ray Crystallography: Structure Solution, Model
Building, and Reﬁnement. Initial phases for CC-pII-I13N
were obtained from molecular replacement (MR) phasing using
PHASER49 with a previously solved coiled-coil X-ray structure
(PDB ID 1BB1) as the search model. For experimental phasing
of CC-pIL-I17N halide sites were identiﬁed from anomalous
data collected at 1.7 Å using SHELXD/E.50 Similarly, for CC-
pII SAD experimental phasing and chain tracing were
successfully carried out with AutoSol in PHENIX.51 In the
case of CC-pIL attempts for SAD phasing failed using either
SHELX or PHENIX. Since diﬀraction data for CC-pIL
extended to 1.6 Å, a structure-solution strategy was employed
that combined MR using PHASER with CC-pIL-I17N as
search model. Molecular replacement was followed by ab initio
phasing in ACORN52 to remove model bias. During model
building and reﬁnement it became apparent that, probably due
to radiation damage during data collection, not all iodide sites
were fully occupied, indicating why experimental phasing using
SAD data may have failed. After obtaining initial phases, further
automated density modiﬁcation and chain tracing using
BUCCANEER53/PARROT54 was carried out followed by
ARP/WARP55 or AutoBuild in PHENIX for automated
model building, where applicable. Subsequent model com-
pletion was carried out by iterative manual modeling in
COOT56 and automated reﬁnement in REFMAC5.57 In the
ﬁnal REFMAC5 stages TLS reﬁnement58 was used for CC-pIL,
CC-pIL-I17N, and CC-pII. TLS parameters were obtained
from the TLSMD server59 generally using one TLS group per
chain. TLS reﬁnement was run such that output PDB ﬁles
contained full B-factors. Final models were checked with
PROCHECK,60 COOT, and MOLPROBITY61 exhibiting good
geometries with no outliers in the Ramachandran plot. A
summary of the reﬁnement and model building statistics
together with PDB accession codes can be found in
Supplementary Table S6. All ﬁgures for the crystallographic
models were prepared using PyMOL (http://www.pymol.org).
Structure solution of CC-pLI has been reported previously.22
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